Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ecallantide for treatment of acute hereditary angioedema attacks: analysis of efficacy by patient characteristics.

Ecallantide for treatment of acute hereditary angioedema attacks: analysis of efficacy by patient characteristics. Allergy Asthma Proc. 2012 Mar-Apr; 33(2):178-85.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.